Staff editor
Kaleido Biosciences is exploring the potential of the microbiome to treat disease and improve human health.
Philippe Lagella of the Instituit National de la Rcherche Agronomique - France, talks about the increasing interest in Faecalibacterium prausnitzii and its possible use.
Bacthera in collaboration with Seres Therapeutics announced to manufacture SER-109, an investigational oral microbiome therapeutic to treat recurrent Clostridioides difficile infection (CDI).
The Microbiome Connect: Gut Therapeutics Summit returns face to face on the 7-8 December. Join the list today whilst tickets are still available and don't forget to use MP10 to…
Dr. Raanan Shamir discusses the role that the intestinal microbiota plays in the development of celiac disease.
20 years ago the world leading groups of experts FAO/WTO defined probiotics microorganisms in food and food supplements
New criteria for the probiotics of the future. We discussed it with Lorenzo Morelli (Catholic University of the Sacred Heart, Italy).
Dr. Christine Robin, the principal investigator at the Henri-Mondor Hospital (Creteil, France), said: “With all my team, we are glad to have recruited the first patient in MICROCARE.”
François Bourdichon presents the IDF's initiative of defining standards and putting a frame beyond probiotics.
Brunella V. Gonzales Cautela (Lallemand) discusses the impact of L. rhamnosus HA-114 on a weight loss program for people suffering of obesity and overweight.
